Amanote Research
Register
Sign In
Targeting MYC for Triple-Negative Breast Cancer Treatment
Oncoscience
- United States
doi 10.18632/oncoscience.414
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 23, 2018
Authors
Unknown
Publisher
Impact Journals, LLC
Related search
Targeting DNA Methylation for Treating Triple-Negative Breast Cancer
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Development of a Vaccine Targeting Triple-Negative Breast Cancer
Triple-Negative Breast Cancer
Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells
British Journal of Cancer
Cancer Research
Oncology
Cetuximab-Conjugates Nanoparticles for the Treatment of Triple Negative Breast Cancer
Platinum-Based Therapy for Triple-Negative Breast Cancer Treatment: A Meta-Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
Triple Negative Breast Cancer: Heterogenous Disease
REVIEWS IN ONCOLOGY
Activity of BET-proteolysis Targeting Chimeric (PROTAC) Compounds in Triple Negative Breast Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
